I imagine a nice "solid" stock price with lots of nice smelling "opportunity" will be just the thing to raise a scad of money from somewhere, issue a fat "good job boys" bonus, before the whole steaming pile comes back to reality.

It's happened too many times to imagine they couldn't pull that off once again. These guys aren't stupid... they are just unethical and probably not very smart about the pharma industry given their own backgrounds.